PSEUDOEPHEDRINE HYDROCHLORIDe (soo-doe-e-fed'rin)
Cenafed, Decongestant Syrup, Dorcol Children's Decongestant, Eltor , Eltor 120 , Halofed, Novafed, PediaCare, Pseudofrin , Robidrine , Sudafed, Sudrin Classifications: alpha- and beta-adrenergic agonist; decongestant; Therapeutic: decongestant Prototype: Epinephrine Pregnancy Category: C
|
Availability
30 mg, 60 mg tablets; 120 mg, 240 mg sustained release tablets; 15 mg/5 mL, 30 mg/5 mL liquid; 7.5 mg/0.8 mL drops
Action
Sympathomimetic amine that produces decongestion of respiratory tract mucosa by stimulating the sympathetic nerve endings
including alpha-, beta-1, and beta-2 receptors. Also acts directly on smooth muscle and constricts renal and vertebral arteries.
Therapeutic Effect
Effective as a nasal decongestant by causing vasoconstriction and thus increasing nasal airway patency.
Uses
Symptomatic relief of nasal congestion associated with rhinitis, coryza, and sinusitis and for eustachian tube congestion.
Contraindications
Hypersensitivity to sympathomimetic amines; severe hypertension; severe coronary artery disease; use within 14 d of MAOIs; hyperthyroidism; prostatic hypertrophy; pregnancy (category C). Safe use in children <2 y is not established.
Cautious Use
Hypertension, heart disease, renal impairment; acute MI, angina; closed-angle glaucoma; concurrent use of ACE INHIBITOR.
Route & Dosage
Nasal Congestion Adult: PO 60 mg q46h or 120 mg sustained release q12h Geriatric: PO 3060 mg q6h prn Child: PO 26 y, 15 mg q46h (max: 60 mg/d); 611 y, 30 mg q46h (max: 120 mg/d)
|
Administration
Oral
- Ensure that sustained release form is not chewed or crushed. Must be swallowed whole.
Adverse Effects (≥1%)
Body as a Whole: Transient stimulation, tremulousness, difficulty in voiding.
CV: Arrhythmias, palpitation,
tachycardia. CNS: Nervousness, dizziness, headache, sleeplessness, numbness of extremities.
GI: Anorexia, dry mouth, nausea, vomiting.
Interactions
Drug: Other
sympathomimetics increase pressor effects and toxicity;
mao inhibitors may precipitate hypertensive crisis;
beta blockers may increase pressor effects; may decrease antihypertensive effects of
guanethidine, methyldopa, reserpine.
Pharmacokinetics
Absorption: Readily from GI tract.
Onset: 1530 min.
Duration: 46 h (812 h sustained release).
Distribution: Crosses placenta; distributed into breast milk.
Metabolism: Partially metabolized in liver.
Elimination: In urine.
Nursing Implications
Assessment & Drug Effects
- Monitor HR and BP, especially in those with a history of cardiac disease. Report tachycardia or hypertension.
Patient & Family Education
- Avoid taking it within 2 h of bedtime because drug may act as a stimulant.
- Discontinue medication and consult physician if extreme restlessness or signs of sensitivity occur.
- Consult physician before concomitant use of OTC medications; many contain ephedrine or other sympathomimetic amines and might
intensify action of pseudoephedrine.